Aimmune Therapeutics, Inc. Information Request Form
Company
Aimmune Therapeutics, Inc.
Ticker
AIMT
Levi & Korsinsky announces it has commenced an investigation ofAimmune Therapeutics, Inc. (NASDAQ:AIMT) concerning possible breaches of fiduciary duty.
To receive more information, please fill out the form.